WebmedCentral Editor
View all WebmedCentral Editors
No Image

Dr. Santiago Ballaz

Staff scientist
University of Navarra

Brief Biography:

I was born in Pamplona-Spain in 1966

Bachelor in Biological Sciences.UniversityofNavarre.Spain. (1991)

Ph.D. in Biological Sciences.UniversityofNavarre.Spain. (1996)  

Postdoctoral Fellow, Molecular and Behavioral Neuroscience Institute (MBNI), TheUniversityofMichigan.USA. (2002 to 2007)

I am currently working at the department of Neuroscience-CIMA of the University of Navarra since 2009.


Academic positions:

Research Associate, Centro de Patogénese Molecular-iMed, Faculty of Pharmacy of Lisbon. (2008)

Lectureship on Psychobiology, PsychologySchool, National Open University. Spain. (1998 to 2001)

Pharmacology Associate Professor,MedicalSchool,UniversityofNavarre.Spain. (1996 to 2000)

Postdoctoral Fellow, Department of Pharmacology,MedicalSchool,University of Navarre,Spain. (1998-2000)

Lectureship on Animal Biology and Physiology,PublicUniversityofNavarre.Spain. (1997-1999)

Assistant professor of Physiology,PharmacySchool,University of Navarre,Spain. (1991-1996).

Assistant Researcher on Toxicology, Institute of Applied Pharmacology, Science & Technology Institute.Spain. (1990).


Research interests:

I am a behavioral-molecular neuroscientist with strong pharmacological background. My research description and published papers reveal that I have been working on the nexus of brain circuits, their molecular functions with individual experience and psychopathology. This work integrates several levels of study ranging from genetics all the way through pharmacology and behavioral paradigms into a cohesive and deeply understandable whole.

In the last two years, I have been working at the Movement Disorders Laboratory of the Research Institute for Applied Medicine. I have developed a human DA-like neuron model (i.e., staurosporine-differentiated SH-SY5Y cells) on which it is possible to study the molecular stimuli leading to either cell death or survival. Mi current research interests are focused in gene regulation of alpha-synuclein as well as how glutamatergic stimuli and ascorbic acid contributes to the pathogenicity of alpha-synuclein.


What I think of the idea behind WebmedCentral:

I consider the Webmed Central a helpful, powerful platform to cast all the finest biomedical research conducted worldwide without the limitations set by the traditional biomedical web sites